TCM

Tang Capital Management Portfolio holdings

AUM $1.98B
1-Year Return 21.62%
This Quarter Return
+46.64%
1 Year Return
+21.62%
3 Year Return
+290.69%
5 Year Return
+284.46%
10 Year Return
+928.34%
AUM
$960M
AUM Growth
-$122M
Cap. Flow
-$239M
Cap. Flow %
-24.9%
Top 10 Hldgs %
38.43%
Holding
146
New
23
Increased
19
Reduced
38
Closed
47

Top Buys

1
INBX
Inhibrx, Inc. Common Stock
INBX
$24.5M
2
OTLK icon
Outlook Therapeutics
OTLK
$19.3M
3
IMNM icon
Immunome
IMNM
$17.8M
4
APLT icon
Applied Therapeutics
APLT
$15.2M
5
EOLS icon
Evolus
EOLS
$14.7M

Top Sells

1
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
$91.5M
2
IMGN
Immunogen Inc
IMGN
$65.2M
3
LIAN
LianBio American Depositary Shares
LIAN
$41.9M
4
AXSM icon
Axsome Therapeutics
AXSM
$25.5M
5
GRCL
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
$22M

Sector Composition

1 Healthcare 98.03%
2 Technology 0.94%
3 Communication Services 0.51%
4 Real Estate 0.32%
5 Financials 0.2%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
SPRY icon
101
ARS Pharmaceuticals
SPRY
$1.06B
– –
-409,463
Closed -$2.24M
STEL icon
102
Stellar Bancorp
STEL
$1.61B
– –
-20,000
Closed -$557K
STIM icon
103
Neuronetics
STIM
$219M
– –
-200,000
Closed -$580K
SWTX
104
DELISTED
SpringWorks Therapeutics
SWTX
– –
-100,000
Closed -$3.65M
XERS icon
105
Xeris Biopharma Holdings
XERS
$1.27B
– –
-150,000
Closed -$353K
ACRS icon
106
Aclaris Therapeutics
ACRS
$224M
– –
-1,753,335
Closed -$1.84M
ADMA icon
107
ADMA Biologics
ADMA
$4.04B
– –
-1,360,000
Closed -$6.15M
ARE icon
108
Alexandria Real Estate Equities
ARE
$14.2B
– –
-10,000
Closed -$1.27M
ASND icon
109
Ascendis Pharma
ASND
$12B
– –
-70,000
Closed -$8.82M
AXSM icon
110
Axsome Therapeutics
AXSM
$6.21B
– –
-320,000
Closed -$25.5M
BEAM icon
111
Beam Therapeutics
BEAM
$1.88B
– –
-350,000
Closed -$9.53M
BIO icon
112
Bio-Rad Laboratories Class A
BIO
$7.83B
– –
-16,000
Closed -$5.17M
BOH icon
113
Bank of Hawaii
BOH
$2.74B
– –
-50,000
Closed -$3.62M
BPMC
114
DELISTED
Blueprint Medicines
BPMC
– –
-50,000
Closed -$4.61M
CVBF icon
115
CVB Financial
CVBF
$2.82B
– –
-300,000
Closed -$6.06M
DVAX icon
116
Dynavax Technologies
DVAX
$1.17B
– –
-300,000
Closed -$4.19M
EDIT icon
117
Editas Medicine
EDIT
$227M
– –
-200,000
Closed -$2.03M
EQ icon
118
Equillium
EQ
$62.5M
– –
-400,000
Closed -$289K
ESPR icon
119
Esperion Therapeutics
ESPR
$510M
– –
-1,850,000
Closed -$5.53M
MEIP icon
120
MEI Pharma
MEIP
$140M
– –
-326,084
Closed -$1.89M
MRNA icon
121
Moderna
MRNA
$9.45B
– –
-76,700
Closed -$7.63M
NKTR icon
122
Nektar Therapeutics
NKTR
$684M
– –
-156,541
Closed -$1.33M
PDSB icon
123
PDS Biotechnology
PDSB
$56.9M
– –
-400,000
Closed -$1.99M
RNAC icon
124
Cartesian Therapeutics
RNAC
$260M
– –
-13,333
Closed -$276K
RVMD icon
125
Revolution Medicines
RVMD
$7.28B
– –
-679,630
Closed -$19.5M
2 3 4
5
6